SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Texas Biotech (TXB)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bill Wexler who wrote (720)7/21/1998 8:18:00 AM
From: Bharat H. Barai  Read Replies (1) of 834
 
Can you tell us what is the basis of your statement that Novastan is fraud? I realize that you are a stock broker and may have reasons to promote or bring down a particular company.

Novastan-Argatroban is a drug already in use in Japan and is working well. I have personally spoken to several MDs who were using the drug during clinical trials and they all loved the drug. I have heard the experience of several leading Hematologists about Argatroban and they all spoke positively about the drug. The multi center trial in USA showed highly significant benefit.

To most Hematologists, non approvable letter by FDA was a rude surprise. In past some low or middle level officials of FDA have shown such irrational behaviour. Later such drugs do get approved, based on the merits.

I would be very surprised if Novastan does not get approved.

B.H. Barai MD
Hematologist
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News